Transcriptomics is the study of the transcriptome, the complete set of RNA molecules transcribed from a cell's genes at a particular time. Because a gene must be copied into RNA before it can be used to make a protein, measuring RNA shows which genes are active in a cell and at what level, and how this changes with disease, treatment or environment. The main tools are DNA microarrays and, more recently, RNA sequencing, including single-cell and spatial methods that measure expression cell by cell or across a tissue sample.
Transcriptomics sits between genomics, which reads the DNA itself, and proteomics, which measures proteins; epigenomics studies the chemical marks that help control expression. For investors it is part of the life-science tools and diagnostics theme: makers of sequencers, reagents and analysis software sell to drug developers and research labs, and expression data feed into drug discovery, including AI-developed drugs.